Provider attitudes, long-acting reversible contraception, and quality of care: A mixed methods study in Tanzania

提供者的态度、长效可逆避孕和护理质量:坦桑尼亚的一项混合方法研究

基本信息

  • 批准号:
    10607843
  • 负责人:
  • 金额:
    $ 3.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-12-01 至 2023-11-30
  • 项目状态:
    已结题

项目摘要

Abstract Global contraceptive programs increasingly promote the use of long-acting reversible contraception (LARC)— implants and intrauterine devices (IUDs)—to reduce the 121 million unintended pregnancies each year. LARCs are highly effective, low maintenance, long lasting, and have lower rates of discontinuation. Unlike other reversible contraceptive methods, LARCs require removal by a clinician to discontinue use. These features have caused providers, advocates, and scholars to promote LARC uptake globally—however, a LARC-first approach may infringe on a client’s right to choose what type of contraceptive method to use and when to stop using a method. Contraceptive programs targeting reduction of unintended pregnancy may engender provider attitudes and behaviors that favor LARCs and restrict client autonomy and choice in contraceptive care. There is little evidence on these dynamics from low- and middle-income countries (LMICs) where LARC use has been explicitly embedded in country-specific contraceptive uptake goals. This study will fill a gap in the literature by (1) describing providers’ attitudes, beliefs, and care practices surrounding LARC- related care, (2) modeling the influence of provider attitudes on clients’ LARC uptake and LARC removals, and (3) assessing the association between quality of care and LARC uptake and LARC removals in a sample of 73 facilities in Dar es Salaam, Tanzania. Tanzania is a compelling setting to study provision and removal of LARCs as use of implants has risen by 1240% since 2004. The Tanzanian government has set explicit targets for increasing LARC use—aiming for 20% and 13% increases in implant and IUD use respectively between 2019 and 2023, increasing the structural emphasis on LARC uptake. A focus on the quality of services is essential to ensure the emphasis on contraceptive uptake has not come at the expense of high-quality, person-centered contraceptive care. The study utilizes three data sources: 29 in-depth interviews with contraceptive providers, a client exit survey capturing 13,036 contraceptive clients seeking either a method of contraception or a LARC removal, and a survey of 259 providers. The proposed study will employ constant comparative thematic qualitative methodology to examine provider attitudes and care practices in the qualitative interviews and hierarchical Bayesian models to jointly model provider- and client-level survey data. Understanding the influence of provider attitudes on LARC uptake, removals, and quality of care will facilitate targeting interventions to address poor quality care.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alexandra Wollum其他文献

Alexandra Wollum的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
  • 批准号:
    10760051
  • 财政年份:
    2023
  • 资助金额:
    $ 3.87万
  • 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
  • 批准号:
    2303692
  • 财政年份:
    2023
  • 资助金额:
    $ 3.87万
  • 项目类别:
    Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
  • 批准号:
    468168
  • 财政年份:
    2022
  • 资助金额:
    $ 3.87万
  • 项目类别:
    Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10427960
  • 财政年份:
    2022
  • 资助金额:
    $ 3.87万
  • 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
  • 批准号:
    10577074
  • 财政年份:
    2022
  • 资助金额:
    $ 3.87万
  • 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
  • 批准号:
    486588
  • 财政年份:
    2022
  • 资助金额:
    $ 3.87万
  • 项目类别:
    Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
  • 批准号:
    2760091
  • 财政年份:
    2022
  • 资助金额:
    $ 3.87万
  • 项目类别:
    Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10621188
  • 财政年份:
    2022
  • 资助金额:
    $ 3.87万
  • 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
  • 批准号:
    10891016
  • 财政年份:
    2021
  • 资助金额:
    $ 3.87万
  • 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
  • 批准号:
    10230365
  • 财政年份:
    2020
  • 资助金额:
    $ 3.87万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了